<?xml version="1.0" encoding="UTF-8"?>
<html>
   <head/>
   <body>
      <div class="hl7Message">
         <p>MSH|^~\&amp;|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|2011053114<br/>0551-0500||ORU^R01^ORU_R01|LRI_5.8_1.1-GU_FRU|D|2.5.1|||AL|NE|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_G<br/>U_Component^^2.16.840.1.113883.9.12^ISO~LAB_FRU_Component^^2.16.840.1.113883.9.83^ISO<br/>
         </p>
         <p>PID|1||PATID1239^^^&amp;2.16.840.1.113883.3.72.5.30.2&amp;ISO^MR||Smirnoff^Peggy^^^^^L||19750401|F||2106-3^White^HL70005^wh^whi<br/>te^L||||||||PATID1239^^^&amp;2.16.840.1.113883.3.72.5.30.2&amp;ISO^MR<br/>
         </p>
         <p>ORC|RE|ORD448811^^2.16.840.1.113883.3.72.5.24^ISO|R-511^^2.16.840.1.113883.3.72.5.25^ISO|||||||||5742200012^Radon^Nicho<br/>las^^^DR^^^&amp;2.16.840.1.113883.4.6&amp;ISO^L^^^NPI<br/>
         </p>
         <p>OBR|1|ORD448811^^2.16.840.1.113883.3.72.5.24^ISO|R-511^^2.16.840.1.113883.3.72.5.25^ISO|HepABC Panel^Hepatitis A B C Pa<br/>nel^L|||20120628070100|||||||||5742200012^Radon^Nicholas^^^DR^^^&amp;2.16.840.1.113883.4.6&amp;ISO^L^^^NPI||||||20110331160428-0<br/>800|||F<br/>
         </p>
         <p>OBX|1|CWE|22314-9^Hepatitis A virus IgM Ab [Presence] in Serum^LN^HAVM^Hepatitis A IgM antibodies (IgM anti-HAV)^L||260<br/>385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||2<br/>0120628100500||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^9006<br/>7^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|2|CWE|20575-7^Hepatitis A virus Ab [Presence] in Serum^LN^HAVAB^Hepatitis A antibodies (anti-HAV)^L||260385009^Nega<br/>tive (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||201206281005<br/>00||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06<br/>037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|3|CWE|16933-4^Hepatitis B virus core Ab [Presence] in Serum^LN^HBVcAB^Hepatitis B core antibodies (anti-HBVc)^L||26<br/>0385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||<br/>20120628100500||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^900<br/>67^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|4|SN|22316-4^Hepatitis B virus core Ab [Units/volume] in Serum^LN^HBcAbQ^Hepatitis B core antibodies (anti-HBVc) Qu<br/>ant^L||^0.40|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|&lt;0.50 IU/mL|N|||F|||20120628070100|||||201206281005<br/>00||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^L^^06<br/>037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|5|CWE|22320-6^Hepatitis B virus e Ab [Presence] in Serum^LN^HBVeAB^Hepatitis B e antibodies (anti-HBVe)^L||26038500<br/>9^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||201206<br/>28100500||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA<br/>^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|6|CWE|5195-3^Hepatitis B virus surface Ag [Presence] in Serum^LN^HBVsAG^Hepatitis B surface antigen (HBsAg)^L||2603<br/>85009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|||||20<br/>120628100500||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067<br/>^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|7|CWE|22322-2^Hepatitis B virus surface Ab [Presence] in Serum^LN^HBVSAB^Hepatitis B surface antibody (anti-HBVs)^L<br/>||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^^^Negative (qualifier value)||Negative|N|||F|||20120628070100|<br/>||||20120628100500||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA<br/>^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|8|CWE|16128-1^Hepatitis C virus Ab [Presence] in Serum^LN^HCVAB^Hepatitis C antibody screen  (anti-HCV)^L||10828004<br/>^Positive (qualifier value)^SCT^POS^POSITIVE^L^^^Positive (qualifier value)||Negative|A|||F|||20120628070100|||||2012062<br/>8100500||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^<br/>L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|9|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^HCVSCO^Hepatitis C antibodies <br/>Signal to Cut-off Ratio^L||^10.8|{s_co_ratio}^Signal to cutoff ratio^UCUM^s/co^^L|0.0-0.9 s/co|H|||F|||20120628070100|||<br/>||20120628100500||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^9<br/>0067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>NTE|1||Negative:   &lt; 0.8; Indeterminate 0.8 - 0.9; Positive:  &gt; 0.9.  In order to reduce<br/>
         </p>
         <p>NTE|2||the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0 and 10.9 be confir<br/>med with additional Verification or PCR testing.<br/>
         </p>
         <p>SPM|1|S2015-777888&amp;&amp;2.16.840.1.113883.3.72.5.24&amp;ISO^S-220713-1&amp;&amp;2.16.840.1.113883.3.72.5.20&amp;ISO||119297000^BLD^SCT^^^^^<br/>^Blood|||||||||||||20110531123551-0800<br/>
         </p>
         <p>ORC|RE||R-512^^2.16.840.1.113883.3.72.5.25^ISO|||||||||5742200012^Radon^Nicholas^^^DR^^^&amp;2.16.840.1.113883.4.6&amp;ISO^L^^^<br/>NPI<br/>
         </p>
         <p>OBR|2||R-512^^2.16.840.1.113883.3.72.5.25^ISO|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Pla<br/>sma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L|||20120628070100||||G|||||5742200012^Radon^<br/>Nicholas^^^DR^^^&amp;2.16.840.1.113883.4.6&amp;ISO^L^^^NPI||||||20110331160428-0800|||C|16128-1&amp;Hepatitis C virus Ab [Presence] <br/>in Serum&amp;LN&amp;HCVAB&amp;Hepatitis C antibody screen  (anti-HCV)&amp;L|||ORD448811&amp;&amp;2.16.840.1.113883.3.72.5.24&amp;ISO^R-511&amp;&amp;2.16.840<br/>.1.113883.3.72.5.25&amp;ISO<br/>
         </p>
         <p>OBX|1|SN|11011-4^Hepatitis C virus RNA [Units/â€‹volume] (viral load) in Serum or Plasma by Probe and target amplificatio<br/>n method^LN^HCVRNA^Hepatitis C RNA PCR^L||^7611200|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L|&lt;43 IU/mL|H||<br/>|F|||20120628070100|||||20120629092700||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test <br/>Park^^Los Angeles^CA^90067^USA^L^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
      </div>
   </body>
</html>